Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Highlight on energy (9) - Green Science Partners sees increasing investor interest and knowledge of green/clean tech space

Friday, March 12, 2010

From Kirsten Bischoff, Opalesque New York:

Launched in July 2009, Stamford, Connecticut-based Green Science Partners LP manages a long/short equity fund focused on the green/clean tech industry. The team behind the launch built the firm with a four-part focus on Investments, Operations, Client Service & Marketing, and Business Management.

“We felt that we needed to build a culture of transparency which emphasizes compliance and regulatory standards, particularly following Wall Streets’ near death experience” says Chris Tagatac, Chief Marketing Officer at Green Science Partners.

In the current asset-raising environment most newly launched vehicles are funded by the managers’ personal assets. Even securing ‘friends and family’ allocations is a much tougher proposition than it was two years ago. Finishing their first six months at year-end 2009 with performance gains of +18% (net), the team at Green Science has ramped up its asset-raising activities. In addition to meeting various types of investors they also hope to attract the attention of seed funds that are putting allocations to work early in the recovery.

Investor knowledge of environmental investing is evolving…. Even over the course of their first six months, the team has witnessed the growth in investor knowledge and interest in green/clean tech investing. Within the US, recent events have made economic growth i......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for